Cargando…

Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China

IMPORTANCE: Dyslipidemia, the prevalence of which historically has been low in China, is emerging as the second leading yet often unaddressed factor associated with the risk of cardiovascular diseases. However, recent national data on the prevalence, treatment, and control of dyslipidemia are lackin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yuan, Zhang, Haibo, Lu, Jiapeng, Ding, Qinglan, Li, Xinyue, Wang, Xiaochen, Sun, Daqi, Tan, Lingyi, Mu, Lin, Liu, Jiamin, Feng, Fang, Yang, Hao, Zhao, Hongyu, Schulz, Wade L., Krumholz, Harlan M., Pan, Xiangbin, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482054/ https://www.ncbi.nlm.nih.gov/pubmed/34586366 http://dx.doi.org/10.1001/jamanetworkopen.2021.27573

Ejemplares similares

Association of Body Mass Index With Blood Pressure Among 1.7 Million Chinese Adults
por: Linderman, George C., et al.
Publicado: (2018)

Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China
por: Mahajan, Shiwani, et al.
Publicado: (2020)

Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention
por: Lu, Yuan, et al.
Publicado: (2018)

Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
por: Wang, Yun, et al.
Publicado: (2018)

Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States
por: Krumholz, Harlan M., et al.
Publicado: (2019)

Evaluation of STEMI Regionalization on Access, Treatment, and Outcomes Among Adults Living in Nonminority and Minority Communities
por: Hsia, Renee Y., et al.
Publicado: (2020)

Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018)

Trends in Racial and Ethnic Disparities in Barriers to Timely Medical Care Among Adults in the US, 1999 to 2018
por: Caraballo, César, et al.
Publicado: (2022)

Association of Graduate Medical Education With Hospital Performance and Patient Outcomes
por: Zinoviev, Radoslav, et al.
Publicado: (2021)

Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia
por: Vardarlı, Aslı Tetik, et al.
Publicado: (2017)

Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018
por: Mu, Lin, et al.
Publicado: (2021)

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk
por: Müller-Wieland, Dirk, et al.
Publicado: (2017)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
por: Cheung, Brian, et al.
Publicado: (2023)

Agile analytics to support rapid knowledge pipelines
por: Schulz, Wade L., et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot
por: Lu, Jiapeng, et al.
Publicado: (2016)

Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus
por: Santos, Mônica, et al.
Publicado: (2013)

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study
por: Khera, Rohan, et al.
Publicado: (2018)

Race and Ethnicity and Emergency Department Discharge Against Medical Advice
por: Tsai, Jennifer W., et al.
Publicado: (2023)

Lipid goal attainment in post‐acute coronary syndrome patients in China: Results from the 6‐month real‐world dyslipidemia international study II
por: Gong, Yanjun, et al.
Publicado: (2021)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Leveraging the Electronic Health Records for Population Health: A Case Study of Patients With Markedly Elevated Blood Pressure
por: Lu, Yuan, et al.
Publicado: (2020)

Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017
por: Zhang, Audrey D., et al.
Publicado: (2020)

Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from Getting to an imprOved Understanding of Low‐Density lipoprotein cholesterol and dyslipidemia management (GOULD)
por: Shaik, Aleesha, et al.
Publicado: (2022)

Quality of Care for Patients Hospitalized for Heart Failure in China
por: Gupta, Aakriti, et al.
Publicado: (2020)

Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States
por: Lu, Yuan, et al.
Publicado: (2018)

Genetic Adaptations of an Island Pit-Viper to a Unique Sedentary Life with Extreme Seasonal Food Availability
por: Lu, Bin, et al.
Publicado: (2020)

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016)

Racial Disparities in Patient Characteristics and Survival After Acute Myocardial Infarction
por: Graham, Garth N., et al.
Publicado: (2018)

Evaluation of Case Volumes of a Heart Transplant Program and Short-term Outcomes After Changes in the United Network for Organ Sharing Donor Heart Allocation System
por: Mori, Makoto, et al.
Publicado: (2020)

Geographic Variation in Process and Outcomes of Care for Patients With Acute Myocardial Infarction in China From 2001 to 2015
por: Zhong, Qi, et al.
Publicado: (2020)

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020
por: Dhingra, Lovedeep S., et al.
Publicado: (2023)

Multicentre methodological study to create a publicly available score of hospital financial standing in the USA
por: Zinoviev, Radoslav, et al.
Publicado: (2021)

Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young Adults
por: Lu, Yuan, et al.
Publicado: (2022)

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020
por: Lu, Yuan, et al.
Publicado: (2023)

Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia
por: Khera, Rohan, et al.
Publicado: (2018)

Association of the Overall Well-being of a Population With Health Care Spending for People 65 Years of Age or Older
por: Riley, Carley, et al.
Publicado: (2018)

Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2019)

Association of Hospital Payment Profiles With Variation in 30-Day Medicare Cost for Inpatients With Heart Failure or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2019)

Evaluation of dyslipidemia in preeclamptic pregnant women and determination of the predictive value of the hemato-lipid profile: A prospective, cross-sectional, case-control study
por: Melekoğlu, Rauf, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fhgnlvmpr9vu5fsjp32fnqnl3